Clinical Trial Update: A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan

View source ↗

Summary

A completed real-world study assessing treatment patterns and burden among chronic myeloid leukemia patients in Japan, sponsored by Novartis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myeloid Leukemia, Chronic | Status: COMPLETED